Tower Research Capital LLC (TRC) - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 70 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$4,136
-75.6%
280
-77.9%
0.00%
Q4 2023$16,977
+18.3%
1,266
+8.8%
0.00%
Q3 2023$14,352
-89.0%
1,164
-89.0%
0.00%
-100.0%
Q2 2023$129,974
+866393.3%
10,567
+755.6%
0.00%
Q1 2023$15
-59.5%
1,235
-61.9%
0.00%
-100.0%
Q4 2022$37
-96.3%
3,242
+1652.4%
0.00%
Q3 2022$1,000185
+208.3%
0.00%
Q2 2022$0
-100.0%
60
-68.9%
0.00%
Q1 2022$1,000
-50.0%
193
-69.3%
0.00%
Q4 2021$2,000628
+837.3%
0.00%
Q3 2021$0
-100.0%
67
-97.4%
0.00%
Q1 2021$16,000
+23.1%
2,579
+32.4%
0.00%
Q4 2020$13,000
+550.0%
1,948
+290.4%
0.00%
Q3 2020$2,0000.0%499
-35.4%
0.00%
Q1 2020$2,000
-75.0%
773
-69.5%
0.00%
-100.0%
Q4 2019$8,000
-38.5%
2,533
-10.9%
0.00%0.0%
Q3 2019$13,000
-35.0%
2,842
-13.8%
0.00%0.0%
Q2 2019$20,000
+233.3%
3,297
+291.1%
0.00%
Q1 2019$6,000
-91.8%
843
-95.6%
0.00%
-100.0%
Q4 2018$73,000
-15.1%
19,063
+18.9%
0.01%
-16.7%
Q3 2018$86,000
+138.9%
16,028
+122.1%
0.01%
+200.0%
Q2 2018$36,000
+157.1%
7,215
+306.9%
0.00%
+100.0%
Q1 2018$14,000
-72.0%
1,773
-48.7%
0.00%
-75.0%
Q3 2017$50,0003,4530.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Rise Advisors, LLC 272$4,1080.00%
DIMENSIONAL FUND ADVISORS LP 318,995$4,826,3940.00%
Covestor Ltd 106$00.00%
Farther Finance Advisors, LLC 77$00.00%
JBF Capital, Inc. 39,637$1,1890.00%
GOLDMAN SACHS GROUP INC 29,807$450,9800.00%
NISA INVESTMENT ADVISORS, LLC 15$00.00%
CWM, LLC 22$00.00%
CALDWELL SUTTER CAPITAL, INC. 7,458$00.00%
RHUMBLINE ADVISERS 2,480$37,5190.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders